Hi PsyaNiteCan you please clarify what you mean by "The top...

First 120 Last

Share
Profile

Follow
peterallan

128 Posts.

32

17/01/25

23:42

Post #: 77456418
Share

Originally posted by PsyaNite: ↑

Dave is still a clown and this is not me praising him what so ever. It's clear this CR and SPP only benefits the few and screws over retail investors and LTH.

What I will say though is this is the best closest thing we've had to any meaningful communication (that was directed at new investors) and that deserves appreciation for what it is.
What will be funny is when these new investors, assuming they're not just going to flip for instant profit, is that it's the last bit of meaningful communication they will ever get from this BoD.

I also find it amusing that Dave couldn't afford to exercise the options he already had without selling to cover the cost, but now he fully intends to participate taking up 30k of the SPP? What, so he can sell them to cover his costs again?

On the technology side, things are looking really positive and I think this is the right path to get absolutely maximum value from this technology (although at a massive dilution compared to 6 years ago). Once we have this test chip, I assume we'll then be able to share with Stanford, and other independent entities that can validate everything that's been claimed.

I've had very conservative estimates this is worth (much to the disagreement of the $1B club) because all we had was IP.
However taking these next steps I'd expect to be able to atleast double my conservative estimates.

Next AGM we should focus on getting the sales pool changed to be more shareholder friendly, but don't waste your time with the EGM. The top holders have all benefited from this bullshit management.

Expand

Hi PsyaNite
Can you please clarify what you mean by "The top holders have all benefited. ..."
I'm a long term holder (about 7 years) in the top 20 list of shareholders and have not benefited in any way whatsoever.
Thanks

4DS Price at posting: 3.9¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 120 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.5¢		Change 0.001(4.17%)		Mkt cap ! $51.52M

Open	High	Low	Value	Volume
2.4¢	2.7¢	2.4¢	$115.3K	4.542M

Buyers (Bids)

No.	Vol.	Price($)
7	490470	2.5¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	1356235	11

View Market Depth

No.	Vol.	Price($)
7	490470	0.025
27	3821060	0.024
22	6981947	0.023
12	6861480	0.022
15	1579332	0.021

Price($)	Vol.	No.
0.026	1356235	11
0.027	1803374	9
0.028	1333346	6
0.029	474694	7
0.030	547908	8

Last trade - 12.02pm 27/06/2025 (20 minute delay)

4DS (ASX) Chart

Hi PsyaNiteCan you please clarify what you mean by "The top...

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi PsyaNiteCan you please clarify what you mean by "The top...

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News